{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:04:55Z","timestamp":1794405895707,"version":"4.9.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current protocols for hematopoietic stem\/progenitor cell (HSPC) gene therapy, involving the transplantation of ex vivo genetically modified HSPCs are complex and not without risk for the patient. We developed a new approach for in vivo HSPC transduction that does not require myeloablation and transplantation. It involves subcutaneous injections of granulocyte-colony-stimulating factor\/AMD3100 to mobilize HSPCs from the bone marrow (BM) into the peripheral blood stream and the IV injection of an integrating, helper-dependent adenovirus (HD-Ad5\/35++) vector system. These vectors target CD46, a receptor that is uniformly expressed on HSPCs. We demonstrated in human CD46 transgenic mice and immunodeficient mice with engrafted human CD34+ cells that HSPCs transduced in the periphery home back to the BM where they stably express the transgene. In hCD46 transgenic mice, we showed that our in vivo HSPC transduction approach allows for the stable transduction of primitive HSPCs. Twenty weeks after in vivo transduction, green fluorescent protein (GFP) marking in BM HSPCs (Lin\u2212Sca1+Kit\u2212 cells) in most of the mice was in the range of 5% to 10%. The percentage of GFP-expressing primitive HSPCs capable of forming multilineage progenitor colonies (colony-forming units [CFUs]) increased from 4% of all CFUs at week 4 to 16% at week 12, indicating transduction and expansion of long-term surviving HSPCs. Our approach was well tolerated, did not result in significant transduction of nonhematopoietic tissues, and was not associated with genotoxicty. The ability to stably genetically modify HSPCs without the need of myeloablative conditioning is relevant for a broader clinical application of gene therapy.<\/jats:p>","DOI":"10.1182\/blood-2016-04-711580","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T22:59:30Z","timestamp":1471993170000},"page":"2206-2217","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":97,"title":["In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors"],"prefix":"10.1182","volume":"128","author":[{"given":"Maximilian","family":"Richter","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamola","family":"Saydaminova","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Yumul","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Krishnan","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"first","affiliation":[{"name":"Institute for Virology and Microbiology, University Witten\/Herdecke, Witten, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eniko-Eva","family":"Nagy","sequence":"first","affiliation":[{"name":"Mobile DNA Group, Max-Delbr\u00fcck Center for Molecular Medicine, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvendra","family":"Singh","sequence":"first","affiliation":[{"name":"Mobile DNA Group, Max-Delbr\u00fcck Center for Molecular Medicine, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Izsv\u00e1k","sequence":"first","affiliation":[{"name":"Mobile DNA Group, Max-Delbr\u00fcck Center for Molecular Medicine, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cattaneo","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, The Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Uckert","sequence":"first","affiliation":[{"name":"Mobile DNA Group, Max-Delbr\u00fcck Center for Molecular Medicine, Berlin, Germany;"},{"name":"Molecular Cell Biology and Gene Therapy Group, Institute of Biology, Humboldt University, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Palmer","sequence":"first","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Haworth","sequence":"first","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"first","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Ehrhardt","sequence":"first","affiliation":[{"name":"Institute for Virology and Microbiology, University Witten\/Herdecke, Witten, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia","family":"Papayannopoulou","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lieber","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA;"},{"name":"Department of Pathology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7573","key":"2020052714005103400_B1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage.","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"2020052714005103400_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-943-3_1","article-title":"Mobilization of hematopoietic stem\/progenitor cells: general principles and molecular mechanisms.","volume":"904","author":"Bonig","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2020052714005103400_B3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3109\/14653240903121245","article-title":"A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.","volume":"11","author":"Fruehauf","year":"2009","journal-title":"Cytotherapy"},{"issue":"7","key":"2020052714005103400_B4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2002-03-0822","article-title":"Evidence that the number of hematopoietic stem cells per animal is conserved in mammals.","volume":"100","author":"Abkowitz","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2020052714005103400_B5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/mt.2013.65","article-title":"Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.","volume":"21","author":"Li","year":"2013","journal-title":"Mol Ther"},{"issue":"11","key":"2020052714005103400_B6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses.","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"2020052714005103400_B7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymthe.2003.12.014","article-title":"Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism.","volume":"9","author":"Nilsson","year":"2004","journal-title":"Mol Ther"},{"issue":"6","key":"2020052714005103400_B8","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1128\/JVI.74.6.2567-2583.2000","article-title":"Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.","volume":"74","author":"Shayakhmetov","year":"2000","journal-title":"J Virol"},{"issue":"12","key":"2020052714005103400_B9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.gt.3301488","article-title":"Efficient infection of primitive hematopoietic stem cells by modified adenovirus.","volume":"8","author":"Yotnda","year":"2001","journal-title":"Gene Ther"},{"issue":"24","key":"2020052714005103400_B10","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.1128\/JVI.01370-06","article-title":"A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.","volume":"80","author":"Tuve","year":"2006","journal-title":"J Virol"},{"issue":"21","key":"2020052714005103400_B11","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"issue":"10","key":"2020052714005103400_B12","doi-asserted-by":"crossref","first-page":"e75344","DOI":"10.1371\/journal.pone.0075344","article-title":"Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration [published correction appears in PLos One. 2014;9(9):e108836].","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"2020052714005103400_B13","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/nar\/gkv031","article-title":"Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses.","volume":"43","author":"M\u00fcck-H\u00e4usl","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2020052714005103400_B14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/mt.2011.47","article-title":"Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.","volume":"19","author":"Moldt","year":"2011","journal-title":"Mol Ther"},{"issue":"2","key":"2020052714005103400_B15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2249.2001.01458.x","article-title":"Membrane cofactor protein (MCP; CD46) expression in transgenic mice.","volume":"124","author":"Kemper","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2020052714005103400_B16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches.","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2020052714005103400_B17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.exphem.2008.01.014","article-title":"Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5\/35 vectors.","volume":"36","author":"Wang","year":"2008","journal-title":"Exp Hematol"},{"issue":"6","key":"2020052714005103400_B18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.","volume":"41","author":"M\u00e1t\u00e9s","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"2020052714005103400_B19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/1074-7613(94)90037-X","article-title":"The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.","volume":"1","author":"Morrison","year":"1994","journal-title":"Immunity"},{"issue":"17","key":"2020052714005103400_B20","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1128\/JVI.79.17.10999-11013.2005","article-title":"A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"2020052714005103400_B21","first-page":"445","article-title":"Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment.","volume":"25","author":"Bradford","year":"1997","journal-title":"Exp Hematol"},{"issue":"9","key":"2020052714005103400_B22","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood-2004-09-3740","article-title":"B-cell kinetics in humans: rapid turnover of peripheral blood memory cells.","volume":"105","author":"Macallan","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2020052714005103400_B23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15283\/ijsc.2008.1.1.55","article-title":"Age-related deterioration of hematopoietic stem cells.","volume":"1","author":"Kim","year":"2008","journal-title":"Int J Stem Cells"},{"issue":"12","key":"2020052714005103400_B24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.cgt.7700981","article-title":"Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.","volume":"13","author":"Ni","year":"2006","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"2020052714005103400_B25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/hum.2005.16.664","article-title":"Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.","volume":"16","author":"Ni","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"12","key":"2020052714005103400_B26","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"2020052714005103400_B27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer.","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"issue":"6","key":"2020052714005103400_B28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/hum.2008.142","article-title":"Transduction of liver metastases after intravenous injection of Ad5\/35 or Ad35 vectors with and without factor X-binding protein pretreatment.","volume":"20","author":"Liu","year":"2009","journal-title":"Hum Gene Ther"},{"issue":"12","key":"2020052714005103400_B29","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/sj.mt.6300319","article-title":"Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.","volume":"15","author":"Stone","year":"2007","journal-title":"Mol Ther"},{"issue":"4","key":"2020052714005103400_B30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2008.297","article-title":"Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.","volume":"17","author":"Seregin","year":"2009","journal-title":"Mol Ther"},{"issue":"6","key":"2020052714005103400_B31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2141.2012.09219.x","article-title":"Engraftment defect of cytokine-cultured adult human mobilized CD34(+) cells is related to reduced adhesion to bone marrow niche elements.","volume":"158","author":"Kallinikou","year":"2012","journal-title":"Br J Haematol"},{"issue":"4","key":"2020052714005103400_B32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2013.12.012","article-title":"Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study.","volume":"14","author":"Kim","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2020052714005103400_B33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2016.04.016","article-title":"In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases.","volume":"19","author":"Biasco","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2020052714005103400_B34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/mt.2015.20","article-title":"Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.","volume":"23","author":"Wang","year":"2015","journal-title":"Mol Ther"},{"issue":"10","key":"2020052714005103400_B35","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.3324\/haematol.2015.127373","article-title":"Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.","volume":"100","author":"Abed","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2020052714005103400_B36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2014.04.016","article-title":"Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle.","volume":"15","author":"Beerman","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2020052714005103400_B37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots.","volume":"110","author":"Schr\u00f6der","year":"2002","journal-title":"Cell"},{"issue":"6","key":"2020052714005103400_B38","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/JVI.79.6.3606-3614.2005","article-title":"Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.","volume":"79","author":"Nakai","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"2020052714005103400_B39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"11","key":"2020052714005103400_B40","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/JVI.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.","volume":"71","author":"Lieber","year":"1997","journal-title":"J Virol"},{"issue":"1-2","key":"2020052714005103400_B41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2020052714005103400_B42","doi-asserted-by":"crossref","first-page":"e1004035","DOI":"10.1371\/journal.ppat.1004035","article-title":"IL-1\u03b1 and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells.","volume":"10","author":"Di Paolo","year":"2014","journal-title":"PLoS Pathog"},{"issue":"5","key":"2020052714005103400_B43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ymthe.2003.07.006","article-title":"The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors [published correction appears in Mol Ther. 2004;9(1):139].","volume":"8","author":"Bernt","year":"2003","journal-title":"Mol Ther"},{"issue":"2","key":"2020052714005103400_B44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2010.08.025","article-title":"Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.","volume":"148","author":"Sakurai","year":"2010","journal-title":"J Control Release"},{"issue":"14","key":"2020052714005103400_B45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.gt.3302749","article-title":"Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.","volume":"13","author":"Sakurai","year":"2006","journal-title":"Gene Ther"},{"issue":"4","key":"2020052714005103400_B46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/mt.2008.19","article-title":"Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.","volume":"16","author":"Sakurai","year":"2008","journal-title":"Mol Ther"},{"issue":"6","key":"2020052714005103400_B47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/hum.2005.16.725","article-title":"Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs.","volume":"16","author":"Beagles","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"2","key":"2020052714005103400_B48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood-2003-07-2324","article-title":"Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning.","volume":"103","author":"Morris","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2020052714005103400_B49","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.gt.3300951","article-title":"Immune response to green fluorescent protein: implications for gene therapy.","volume":"6","author":"Stripecke","year":"1999","journal-title":"Gene Ther"},{"issue":"7","key":"2020052714005103400_B50","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.V97.7.1951","article-title":"Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells.","volume":"97","author":"Rosenzweig","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2020052714005103400_B51","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1073\/pnas.94.9.4686","article-title":"Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.","volume":"94","author":"Kay","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020052714005103400_B52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/imr.12128","article-title":"Hematopoietic stem cells for cancer immunotherapy.","volume":"257","author":"Gschweng","year":"2014","journal-title":"Immunol Rev"},{"issue":"8","key":"2020052714005103400_B53","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.","volume":"28","author":"Holt","year":"2010","journal-title":"Nat Biotechnol"}],"updated-by":[{"DOI":"10.1182\/blood.2019003065","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/18\/2206\/1737276\/2206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/18\/2206\/1737276\/2206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T16:32:17Z","timestamp":1692462737000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/18\/2206\/35488\/In-vivo-transduction-of-primitive-mobilized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":53,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,11,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-04-711580","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726669175.793568494","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}